1. Home
  2. /
  3. Available
  4. /
  5. WHO Preferred Product Characteristics for New Tuberculosis Vaccine

WHO Preferred Product Characteristics for New Tuberculosis Vaccine

Description

The document presents WHO preferences for new tuberculosis vaccines, driven by the high medical need for contribution to the fight against TB, in alignment with the End TB strategy. Priorities are for a vaccine to be administered to adolescents and adults for prevention of pulmonary tuberculosis and reduction of transmission, and for a pediatric vaccine with improved safety and efficacy as compared to BCG.

Project details

Country
Year
Target Group
Vaccine
Type of research
Partners involved

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?